SEO URLwww.firestrike.ai/deals/ventyx-biosciences-lilly-acquisition-2026
acquisitionAnnounced · Jan 6, 2026PharmaceuticalsSource · CredibleArticle · Factual
Lilly acquires Ventyx Biosciences
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$1B
Target
Ventyx Biosciences
NASDAQ: VTYX · San Diego, California
Acquirer
Lilly
Full Acquisition
Status
Announced
Lilly agreed to acquire Ventyx Biosciences. Reported deal value: $1B. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: San Diego, California, United States.
This page summarizes publicly available information about the transaction as of 2026-01-06. Figures and status may change as filings and press coverage update.
Shares of Ventyx Biosciences , Inc. surged more than 62 % in after-hours trading on Tuesday after The Wall Street Journal reported that the company is in advanced talks to be acquired by Eli Lilly and Company in a deal valued at over $1 billion
Deal timeline
Announced
Jan 6, 2026 · nasdaq.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $1B. Figures and status may change as sources update.
Sources: nasdaq.com · Primary article · FireStrike proprietary index